Last updated on February 2019

Post-marketing Surveillance Study of Adalimumab (Humira ) for Non-infectious Intermediate Posterior or Panuveitis Patients


Brief description of study

The objective of this study is to evaluate the safety and effectiveness of Humira (Adalimumab) for the treatment of non-infectious intermediate, posterior, or panuveitis patients under a routine treatment practice.

Clinical Study Identifier: NCT03339102

Contact Investigators or Research Sites near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.